Therefore, our results suggest that the bioactive constituent of Aloe perryi extracts could serve as a targeted therapy for estrogen receptor α positive breast cancer or androgen receptor prostate cancer, which warrant further research and investigations [46]. Here, ESR1 is linked to breast carcinoma.